U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07057635) titled 'Wireless Irradiance SEnsors During Neonatal Phototherapy' on June 30.
Brief Summary: Bilisensors are devices designed to measure the cumulative dose of phototherapy administered to neonates undergoing treatment for hyperbilirubinemia. The current standard of care typically involves intermittent spot measurements once a day using a handheld dosimeter that may give variable estimations. In contrast, bilisensors may enable continuous, real-time monitoring of light exposure, helping to know the total phototherapy dose received by the infant.
Study Start Date: July 10
Study Type: OBSERVATIONAL
Condition:
Neonatal Hyperbilirubinemia
J...